# MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection

> **NCT00614458** · PHASE2 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 6 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Raltegravir; valproic acid

## Key facts

- **NCT ID:** NCT00614458
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to insufficient funds
- **Last updated:** 2011-10-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614458, "MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00614458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*